Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 13 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 9 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (10)
Early P 1 (1)
P 1 (1)
P 2 (1)

Trial Status

Completed9
Not Yet Recruiting1
Recruiting1
Unknown1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT06995586Not ApplicableNot Yet Recruiting

Dietary Supplements in Patients With Coronary Artery Bypass Grafting for Improving the Quality of Healthcare Delivery.

NCT03925597Not ApplicableActive Not RecruitingPrimary

Multiomic Signatures of Microbial Metabolites Following Prebiotic Fiber Supplementation

NCT05821010Phase 2Recruiting

Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis

NCT05584254Not ApplicableCompleted

Effects of β-glucans on Gut Permeability and Microbiota in Elderly

NCT04706858Not ApplicableCompletedPrimary

Integrative Personal Omics Profiling for Dynamic Molecular Phenotypes Monitoring During Fiber Supplementation

NCT04043000Not ApplicableCompleted

Super 13 Pro & Prebiotics on the Human Intestinal Microflora

NCT02118402Not ApplicableCompleted

Iron and Prebiotics Fortification in Kenyan Infants

NCT03336385Not ApplicableCompletedPrimary

Prebiotic Supplementation and Intestinal Barrier Function in Elderly: a RCT

NCT03554694Not ApplicableUnknownPrimary

Gut-brain Axis, Brain Function, and Behaviour.

NCT03312660Not ApplicableCompletedPrimary

Effect of a Kefir Beverage on Immunity and Lipid Profile

NCT02679183Early Phase 1CompletedPrimary

Medically-Graded Honey Supplementation Formula To Preterm Infants

NCT01549782Not ApplicableCompletedPrimary

Mixture of Prebiotics on Intestinal Microbiota of Patients Receiving Abdominal Radiotherapy.

NCT01201577Phase 1Completed

Biological Modulation of Bacterial QSSMs, Innate and Adaptive Immunity by Antibiotics, Probiotics and Prebiotics in Healthy Individuals

Showing all 13 trials

Research Network

Activity Timeline